72 related articles for article (PubMed ID: 6686049)
1. [No effect of particular r-RNA fragments on cytostatic-induced myelosuppression in a rat transplanted tumor model].
Berger M; Zeller WJ
Arzneimittelforschung; 1983; 33(10):1477-8. PubMed ID: 6686049
[TBL] [Abstract][Full Text] [Related]
2. Transfection with a bcl-2 expression vector protects transplanted bone marrow from chemotherapy-induced myelosuppression.
Kondo S; Yin D; Morimura T; Oda Y; Kikuchi H; Takeuchi J
Cancer Res; 1994 Jun; 54(11):2928-33. PubMed ID: 7514494
[TBL] [Abstract][Full Text] [Related]
3. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
4. Extract of astragalus membranaceus and ligustrum lucidum does not prevent cyclophosphamide-induced myelosuppression.
Khoo KS; Ang PT
Singapore Med J; 1995 Aug; 36(4):387-90. PubMed ID: 8919152
[TBL] [Abstract][Full Text] [Related]
5. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.
Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR
Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315
[TBL] [Abstract][Full Text] [Related]
6. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
[TBL] [Abstract][Full Text] [Related]
7. [Studies on the changes in bone marrow pictures after surgical operations in combination with the administration of anticancer agents].
Anzai S
Kumamoto Igakkai Zasshi; 1968 Nov; 42(11):708-44. PubMed ID: 5756098
[No Abstract] [Full Text] [Related]
8. Tyrphostin 4-nitrobenzylidene malononitrile reduces chemotherapy toxicity without impairing efficacy.
Novogrodsky A; Weisspapir M; Patya M; Meshorer A; Vanichkin A
Cancer Res; 1998 Jun; 58(11):2397-403. PubMed ID: 9622080
[TBL] [Abstract][Full Text] [Related]
9. Changes in marrow myelopoietic and lymphoid cell counts after repeated cyclophosphamide administration in the rat.
Berger J
Haematologia (Budap); 1981 Dec; 14(4):407-16. PubMed ID: 7344975
[TBL] [Abstract][Full Text] [Related]
10. Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycin.
Tannock I
Cancer Res; 1983 May; 43(5):2059-62. PubMed ID: 6831436
[TBL] [Abstract][Full Text] [Related]
11. The use of low-dose methotrexate for the treatment of allograft rejection is associated with significant drug toxicity.
Robinson JA; Costanzo-Nordin MR; Grusk BB; Silver MA; Sobotka PA; O'Connell JB; Pifarre R
Bibl Cardiol; 1988; (43):35-8. PubMed ID: 3067720
[No Abstract] [Full Text] [Related]
12. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
Lopez M; Mary JY; Sainteny F
Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
[TBL] [Abstract][Full Text] [Related]
14. High-dose chemotherapy with autologous marrow rescue for malignant brain tumors: analysis of the impact of prior chemotherapy and cranio-spinal irradiation on hematopoietic recovery.
Faulkner LB; Lindsley KL; Kher U; Heller G; Black P; Finlay JL
Bone Marrow Transplant; 1996 Mar; 17(3):389-94. PubMed ID: 8704692
[TBL] [Abstract][Full Text] [Related]
15. [Study of bone marrow cellularity in selective testing of the anti-tumor action of cytostatic drugs. Determination of the optimum of selectivity].
Rosin S
Stud Cercet Med Interna; 1967; 8(1):89-96. PubMed ID: 6043548
[No Abstract] [Full Text] [Related]
16. Influence of indomethacin and other anti-inflammatory drugs on mobilization and production of neutrophils: studies with carrageenan-induced inflammation in rats.
Almeida AP; Bayer BM; Horakova Z; Beaven MA
J Pharmacol Exp Ther; 1980 Jul; 214(1):74-9. PubMed ID: 7391973
[TBL] [Abstract][Full Text] [Related]
17. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
Tam YK; Klingemann HG
Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model.
Neuwelt EA; Pagel MA; Hasler BP; Deloughery TG; Muldoon LL
Cancer Res; 2001 Nov; 61(21):7868-74. PubMed ID: 11691805
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and toxicity of ifosfamide stereoisomers in an in vivo rat mammary carcinoma model.
Wainer IW; Granvil CP; Wang T; Batist G
Cancer Res; 1994 Aug; 54(16):4393-7. PubMed ID: 8044787
[TBL] [Abstract][Full Text] [Related]
20. [The effect of D-glucuronic acid on the regenerative processes of granulomonocytopoiesis in cytostatic-induced myelodepression].
Gol'dberg ED; Dygaĭ AM; Karpova GV; Simanina EV; Khlusov IA; Shakhov VP; Agafonov VI
Eksp Klin Farmakol; 1993; 56(6):25-8. PubMed ID: 8111290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
